Allergan, a Botox maker, accepted a $66 billion takeover bid from pharmaceutical company Actavis. Actavis offered $219 per share in cash and stock, and its shares rose 1.7 percent to $247.94.
Actavis successfully completed its tender offer to purchase all outstanding shares of Durata Therapeutics. Actavis offered to purchase all outstanding shares of Durata for $23 per share in cash or approximately $675 million total.
Johnson & Johnson is seeking an excess of $5 billion in damages from Boston Scientific related to a decade-old bidding war over device company Guidant, according to a Reuters report.
Cantel Medical, the parent company of Medivators, promoted Jorgen Hansen from executive vice president and COO to president and COO.
Salix Pharmaceuticals executive vice president William P. Forbes sold 11,079 shares of the company’s stock for a total of $1.05 million, according to a Mideast Times report.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.
More articles on gastroenterology:
7 must-reads on CRC screenings & treatments
American Cancer Society honors 2 GI surgeons
6 GI physicians in the news
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
